Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia.

Veröffentlicht vonadmin

Tinhofer I, Marschitz I, Kos M, Henn T, Egle A, Villunger A, Greil R.

http://www.ncbi.nlm.nih.gov/pubmed/9596676